Cillian King

Cillian King is an Investment Manager at LSP, one of Europe’s leading Life Sciences investors, and is fully dedicated to the LSP Dementia Fund.

Prior to joining LSP, Cillian was an Investment Manager at Swanbridge Capital, a venture fund focused on early-stage life sciences companies. At Swanbridge, Cillian led seed investments into biotech companies and served on the Boards of Allero Therapeutics and Pan Cancer T. Cillian is a molecular biologist by training and holds a PhD in Molecular Neurosciences.